EGFR and neoplasm: The quinazoline core, as an advantageous structural framework for drug development, is widely used in the research of anti-tumor drugs, among which the research on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is the most active [20].